bf/NASDAQ:SRPT_icon.jpeg

COM:SAREPTA

Sarepta Therapeutics

  • Stock

Last Close

110.50

22/11 21:00

Market Cap

14.11B

Beta: -

Volume Today

872.57K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-111.98M
-
-135.79M
21.26%
-220.03M
62.04%
-267.26M
21.47%
-50.69M
81.03%
-361.92M
614.01%
-715.08M
97.58%
-554.13M
22.51%
-418.78M
24.43%
-703.49M
67.99%
-535.98M
23.81%
depreciation and amortization
1.28M
-
3.69M
188.96%
5.25M
42.20%
5.61M
6.94%
8.09M
44.22%
12.24M
51.32%
30.55M
149.47%
26.91M
11.90%
38.02M
41.27%
41.86M
10.12%
58.89M
40.67%
deferred income tax
11.49M
-
5.34M
53.53%
849K
84.10%
373K
56.07%
-83K
122.25%
-1.41M
1,601.20%
-8.45M
498.09%
10.64M
226.02%
15.81M
48.59%
383.55M
-
stock based compensation
11.13M
-
20.34M
82.84%
32.12M
57.86%
29.96M
6.71%
30.46M
1.68%
50.13M
64.54%
78.60M
56.81%
108.07M
37.49%
113.94M
5.43%
233.02M
104.50%
182.51M
21.67%
change in working capital
12.27M
-
-22.14M
280.42%
31.98M
244.49%
-15.77M
149.29%
-97.46M
518.13%
-107.89M
10.70%
-66.88M
38.01%
554.06M
928.42%
-98.17M
117.72%
-39.47M
59.79%
-481.09M
1,118.87%
accounts receivables
2.80M
-
1.11M
60.23%
-1.56M
240.13%
-1.25M
19.86%
-24.24M
1,837.65%
-19.58M
19.24%
-41.84M
113.71%
-10.46M
74.99%
-51.65M
393.74%
-61.64M
19.34%
-185.70M
201.27%
inventory
-234.84M
-
-244.94M
4.30%
-147M
39.99%
-12.81M
91.28%
-70.79M
452.50%
-41.84M
40.90%
-45.93M
9.78%
-60.58M
31.89%
-83.77M
38.28%
-50.78M
39.38%
-147.71M
190.89%
accounts payables
9.47M
-
10.76M
13.68%
18.30M
70.00%
7.31M
60.05%
12.93M
76.84%
90.16M
597.58%
122.98M
36.40%
42.00M
65.85%
23.30M
44.53%
147.57M
533.44%
-50.13M
133.97%
other working capital
234.84M
-
210.93M
10.18%
162.25M
23.08%
-9.01M
105.55%
-15.35M
70.37%
-136.64M
789.92%
-102.09M
25.28%
583.10M
671.16%
13.96M
97.61%
-74.62M
634.59%
-97.54M
30.71%
other non cash items
11.13M
-
12K
99.89%
367K
2,958.33%
1.27M
244.96%
-122.32M
9,762.01%
20.19M
116.51%
224.79M
1,013.37%
-38.09M
116.94%
-94.00M
146.81%
142.73M
251.84%
-108.88M
176.28%
net cash provided by operating activities
-64.69M
-
-128.54M
98.68%
-149.47M
16.28%
-245.82M
64.47%
-232.00M
5.62%
-388.66M
67.53%
-456.46M
17.45%
107.47M
123.54%
-443.17M
512.38%
-325.35M
26.59%
-500.99M
53.99%
investments in property plant and equipment
-3.77M
-
-26.82M
610.60%
-4.83M
81.98%
-6.87M
42.06%
-21.21M
208.99%
-64.34M
203.30%
-62.71M
2.54%
-82.20M
31.08%
-38.49M
53.18%
-30.82M
19.92%
-87.34M
183.37%
acquisitions net
1.38M
-
1.43M
3.69%
1.52M
6.49%
-9.21M
704.26%
3.19M
134.60%
-172.56M
5,512.67%
purchases of investments
-7.90M
-
-274.37M
3,374.33%
-172.70M
37.06%
-195.43M
13.16%
-589.52M
201.66%
-1.17B
98.80%
-1.19B
1.85%
-1.33B
11.72%
-29.99M
97.75%
-1.94B
6,358.77%
-2.05B
5.79%
sales maturities of investments
142.16M
-
185.94M
30.79%
112.10M
39.71%
306.92M
173.79%
865.81M
182.10%
1.72B
98.15%
1.19B
30.67%
466M
60.82%
923.22M
98.12%
1.87B
102.39%
other investing activites
-1.38M
-
-1.43M
3.69%
-1.52M
6.49%
134.22M
8,900.98%
-3.19M
102.38%
104.57M
-
97.89M
6.39%
-2.43M
102.48%
102M
4,302.72%
net cash used for investing activites
-11.67M
-
-159.03M
1,262.49%
8.41M
105.29%
-90.19M
1,172.45%
-178.81M
98.26%
-370.49M
107.19%
286.73M
177.39%
-121.72M
142.45%
495.41M
507.01%
-1.05B
311.32%
-165.80M
84.16%
debt repayment
-89K
-
-94K
5.62%
-2.60M
2,663.83%
-7.60M
192.65%
-54.75M
620.16%
-267.22M
388.04%
-244.94M
8.34%
-291.11M
18.85%
-823.23M
-
-73.76M
91.04%
common stock issued
145.99M
-
104.25M
28.59%
130.81M
25.47%
364.80M
178.89%
353.96M
2.97%
513.41M
45.05%
365.35M
28.84%
312.05M
14.59%
548.53M
75.78%
30.04M
94.52%
51.25M
70.58%
common stock repurchased
-4.34M
-
-4.80M
10.63%
-7.76M
61.84%
dividends paid
-240.60M
-
-286.31M
19.00%
other financing activites
-226K
-
19.60M
-
20.93M
6.78%
588.88M
2,713.55%
283.96M
51.78%
767.07M
170.13%
952.49M
24.17%
20.80M
97.82%
1.03B
4,830.76%
147.52M
85.62%
net cash used provided by financing activities
145.67M
-
104.16M
28.50%
147.81M
41.91%
378.13M
155.82%
888.08M
134.86%
530.15M
40.30%
642.55M
21.20%
682.32M
6.19%
561.57M
17.70%
232.51M
58.60%
125.00M
46.24%
effect of forex changes on cash
3.44M
-
net change in cash
69.30M
-
-183.41M
364.65%
6.75M
103.68%
42.12M
523.66%
477.27M
1,033.23%
-229.00M
147.98%
472.82M
306.47%
668.07M
41.30%
613.81M
8.12%
-1.14B
285.68%
-538.35M
52.77%
cash at beginning of period
187.66M
-
256.96M
36.93%
73.55M
71.38%
80.30M
9.18%
122.56M
52.62%
599.83M
389.43%
370.83M
38.18%
843.64M
127.50%
1.51B
79.19%
2.13B
40.60%
966.78M
54.52%
cash at end of period
256.96M
-
73.55M
71.38%
80.30M
9.18%
122.42M
52.45%
599.83M
389.97%
370.83M
38.18%
843.64M
127.50%
1.51B
79.19%
2.13B
40.60%
985.80M
53.62%
428.43M
56.54%
operating cash flow
-64.69M
-
-128.54M
98.68%
-149.47M
16.28%
-245.82M
64.47%
-232.00M
5.62%
-388.66M
67.53%
-456.46M
17.45%
107.47M
123.54%
-443.17M
512.38%
-325.35M
26.59%
-500.99M
53.99%
capital expenditure
-3.77M
-
-26.82M
610.60%
-4.83M
81.98%
-6.87M
42.06%
-21.21M
208.99%
-64.34M
203.30%
-62.71M
2.54%
-82.20M
31.08%
-38.49M
53.18%
-30.82M
19.92%
-87.34M
183.37%
free cash flow
-68.47M
-
-155.36M
126.91%
-154.30M
0.69%
-252.69M
63.76%
-253.21M
0.21%
-453.00M
78.90%
-519.18M
14.61%
25.26M
104.87%
-481.66M
2,006.52%
-356.17M
26.05%
-588.34M
65.18%

All numbers in (except ratios and percentages)